1-7 of 7
Elizabeth Hexner
Close
Sort by
Journal Articles

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

Aaron Etra, Najla El Jurdi, Nikolaos Katsivelos, Deukwoo Kwon, Stephanie Gergoudis, George Morales, Nikolaos Spyrou, Steven Kowalyk, Paibel Aguayo-Hiraldo, Yu Akahoshi, Francis Ayuk, Janna Baez, Brian C. Betts, Chantiya Chanswangphuwana, Yi-Bin Chen, Hannah Choe, Zachariah DeFilipp, Sigrun Gleich, Elizabeth Hexner, William J. Hogan, Ernst Holler, Carrie L. Kitko, Sabrina Kraus, Monzr Al Malki, Margaret MacMillan, Attaphol Pawarode, Francesco Quagliarella, Muna Qayed, Ran Reshef, Tal Schechter, Ingrid Vasova, Daniel Weisdorf, Matthias Wölfl, Rachel Young, Ryotaro Nakamura, James L. M. Ferrara, John E. Levine, Shernan Holtan
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3284–3292.
https://doi.org/10.1182/bloodadvances.2023011049
Published: 2024
Includes: Supplemental data
Journal Articles

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

Clinical Trials & Observations
Monzr M. Al Malki, Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra, Hannah Choe, Elizabeth Hexner, Amelia Langston, Sunil Abhyankar, Doris M. Ponce, Zachariah DeFilipp, Carrie L. Kitko, Kehinde Adekola, Ran Reshef, Francis Ayuk, Alexandra Capellini, Chantiya Chanswangphuwana, Matthias Eder, Gilbert Eng, Isha Gandhi, Stephan Grupp, Sigrun Gleich, Ernst Holler, Nora Rebeka Javorniczky, Stelios Kasikis, Steven Kowalyk, George Morales, Umut Özbek, Wolf Rösler, Nikolaos Spyrou, Gregory Yanik, Rachel Young, Yi-Bin Chen, Ryotaro Nakamura, James L. M. Ferrara, John E. Levine
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5189–5198.
https://doi.org/10.1182/bloodadvances.2023009853
Published: 2023
Includes: Supplemental data
Journal Articles

The utility of biomarkers in acute GVHD prognostication

Clinical Trials & Observations
Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra, William J. Hogan, Wolf Rösler, Elizabeth Hexner, Zachariah DeFilipp, Ran Reshef, Chantiya Chanswangphuwana, Muna Qayed, Sabrina Kraus, Matthias Eder, Nora Rebeka Javorniczky, Stephan A. Grupp, Carrie L. Kitko, Pietro Merli, Paibel Aguayo-Hiraldo, Matthias Wölfl, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Nikolaos Katsivelos, Alina Khan, Steven Kowalyk, George Morales, Rachel Young, Ryotaro Nakamura, Yi-Bin Chen, John E. Levine, James L. M. Ferrara
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5152–5155.
https://doi.org/10.1182/bloodadvances.2023009929
Published: 2023
Includes: Supplemental data
Journal Articles

Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification

Aaron Etra, Stephanie Gergoudis, George Morales, Nikolaos Spyrou, Jay Shah, Steven Kowalyk, Francis Ayuk, Janna Baez, Chantiya Chanswangphuwana, Yi-Bin Chen, Hannah Choe, Zachariah DeFilipp, Isha Gandhi, Elizabeth Hexner, William J. Hogan, Ernst Holler, Urvi Kapoor, Carrie L. Kitko, Sabrina Kraus, Jung-Yi Lin, Monzr Al Malki, Pietro Merli, Attaphol Pawarode, Michael A. Pulsipher, Muna Qayed, Ran Reshef, Wolf Rösler, Tal Schechter, Grace Van Hyfte, Daniela Weber, Matthias Wölfl, Rachel Young, Umut Özbek, James L. M. Ferrara, John E. Levine
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3707–3715.
https://doi.org/10.1182/bloodadvances.2022007296
Published: 2022
Includes: Supplemental data
Journal Articles

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Clinical Trials & Observations
John O. Mascarenhas, Raajit K. Rampal, Heidi E. Kosiorek, Rupali Bhave, Elizabeth Hexner, Eunice S. Wang, Aaron Gerds, Camille N. Abboud, Marina Kremyanskaya, Dimitry Berenzon, Olatoyosi Odenike, Noushin Farnoud, Aishwarya Krishnan, Rona Singer Weinberg, Erin McGovern, Mohamed E. Salama, Vesna Najfeld, Juan S. Medina-Martinez, Juan E. Arango Ossa, Max F. Levine, Yangyu Zhou, Lonette Sandy, Mark L. Heaney, Ross L. Levine, Ruben A. Mesa, Amylou C. Dueck, Ronald Hoffman
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5246–5256.
https://doi.org/10.1182/bloodadvances.2020002119
Published: 2020
Includes: Supplemental data
Journal Articles

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms

Clinical Trials & Observations
Raajit K. Rampal, John O. Mascarenhas, Heidi E. Kosiorek, Leah Price, Dmitriy Berenzon, Elizabeth Hexner, Camille N. Abboud, Marina Kremyanskaya, Rona Singer Weinberg, Mohamed E. Salama, Kamal Menghrajani, Vesna Najfeld, Lonette Sandy, Mark L. Heaney, Ross L. Levine, Ruben A. Mesa, Amylou C. Dueck, Judith D. Goldberg, Ronald Hoffman
Journal: Blood Advances
Blood Adv (2018) 2 (24): 3572–3580.
https://doi.org/10.1182/bloodadvances.2018019661
Published: 2018
Includes: Supplemental data
Journal Articles

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802

Clinical Trials & Observations
Shernan G. Holtan, Todd E. DeFor, Angela Panoskaltsis-Mortari, Nandita Khera, John E. Levine, Mary E. D. Flowers, Stephanie J. Lee, Yoshihiro Inamoto, George L. Chen, Sebastian Mayer, Mukta Arora, Jeanne Palmer, Corey S. Cutler, Sally Arai, Aleksandr Lazaryan, Laura F. Newell, Madan H. Jagasia, Iskra Pusic, William A. Wood, Anne S. Renteria, Gregory Yanik, William J. Hogan, Elizabeth Hexner, Francis Ayuk, Ernst Holler, Udomsak Bunworasate, Yvonne A. Efebera, James L. M. Ferrara, Joseph Pidala, Alan Howard, Juan Wu, Javier Bolaños-Meade, Vincent Ho, Amin Alousi, Bruce R. Blazar, Daniel J. Weisdorf, Margaret L. MacMillan
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1882–1888.
https://doi.org/10.1182/bloodadvances.2018017343
Published: 2018
Includes: Supplemental data